BIOQUÍMICA Y BIOLOGÍA MOLECULAR III E INMUNOLOGÍA

2007

1. Analysis of HLA class I alterations in tumors: Choosing a strategy based on known patterns of underlying molecular mechanisms

   Tissue Antigens

2. Different mechanisms can lead to the same altered HLA class I phenotype in tumors

   Tissue Antigens

3. Distribution of HLA class I altered phenotypes in 92 melanoma cell lines

   TISSUE ANTIGENS

4. Emerging roles of vasoactive intestinal peptide: A new approach for autoimmune therapy

   Annals of the Rheumatic Diseases

5. HLA class I antigen expression and tumor immune escape

   13TH INTERNATIONAL CONGRESS OF IMMUNOLOGY

6. HLA total loss: different molecular mechanisms found in different tumor cell lines

   TISSUE ANTIGENS

7. Identification of different tumor escape mechanisms in several metastases from a melanoma patient undergoing immunotherapy

   Cancer Immunology, Immunotherapy

8. Intentional mixed buccal cell reference sample in a paternity case

   Journal of Forensic Sciences

9. International conference: Progress in vaccination against cancer-2006 (PIVAC 6), Granada, Spain

   Cancer Immunology, Immunotherapy

10. NKG2D polymorphism is not associated with risk of renal cell cancer or colon carcinoma in a study of the population in south of Spain

    TISSUE ANTIGENS

11. Polymorphisms within CTLA-4 gene are associated with the risk of development of renal cancer

    TISSUE ANTIGENS

12. Preoperative diagnosis of papillary thyroid carcinoma by detection of B-RAF (T1799A) mutation on fine needle aspiration biopsy specimens

    HORMONE RESEARCH

13. Role of altered expression of HLA class i molecules in cancer progression

    Advances in Experimental Medicine and Biology